Sona-Exim reached #3 position in the Ukrainian ophthalmology market in April 2026, demonstrating 19% sales growth and strong market performance in a declining category.
Sona-Exim reached #3 position in the Ukrainian ophthalmology market in April 2026, demonstrating 19% sales growth and strong market performance in a declining category.
For over 20 years, Sona Group has worked in reproductive medicine, helping make innovative treatment solutions accessible to patients across different countries.
Sona Group team joined the European Business Association session on intercultural meetings to explore how global teams build clearer, stronger communication across cultures.
Sona-Exim shares how AI inside CRM helps reduce routine work, support planning and improve execution across pharma markets.
Sona Group announces the start of its cooperation with Pharmacare Srl, strengthening its international network and expanding pharmaceutical collaboration across Europe.
APRaD and Sona-Pharm emphasize HTA transparency, pricing policy, and strategic healthcare reforms as essential for access to innovative medicines in Ukraine
Insights from the Ophthalmic Synergy masterclass in Kyiv on multidisciplinary ophthalmology, dry eye disease, and broader clinical decision-making.
Explore 5 key questions about a career in pharma, what employers look for, and how to prepare before sending your CV.
ophthalmology Sona Group

Development. Respect. Integrity. Valour. Engagement. Success.

Sona-Exim Kazakhstan, part of Sona Group, held its traditional cycle meeting in the historic city of Samarkand, Uzbekistan - celebrating outstanding team results and setting ambitious goals for 2026.